United States Ovarian Cancer Diagnostics Market Poised for Breakthrough Growth with Advanced Early Detection Technologies 2025 | Major key players - Thermo Fisher Scientific, Abbott, Myriad Genetic Laboratories, Inc.

Market Overview:

The Ovarian Cancer Diagnostics Market is estimated to reach at a CAGR of 6.8% during the forecast period (2024-2031).

The Ovarian Cancer Diagnostics Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/ovarian-cancer-diagnostics-market?sz

The Ovarian Cancer Diagnostics Market involves the development, production, and commercialization of tests and technologies used to detect ovarian cancer at early and advanced stages. It includes biomarkers, imaging, molecular diagnostics, and screening tools aimed at improving accuracy, early detection, and patient outcomes. Growing awareness, technological advancements, and rising prevalence drive market expansion globally.

Recent Key Developments of United States (U.S):

Aug 2025: An AI-powered multi-omic blood test for ovarian cancer detection in symptomatic women showed high accuracy (e.g., 92% AUC for all-stage) in peer-reviewed data, outperforming traditional biomarkers like CA125.

Jul 2025: Research at MD Anderson identified PPP2R1A mutations as a predictive biomarker for improved survival in ovarian clear cell carcinoma patients treated with immunotherapy.

Sep 2025: The FDA accepted a New Drug Application (NDA) for the treatment relacorilant (used with nab-paclitaxel) for platinum-resistant ovarian cancer, based on clinical data showing improved progression-free and overall survival.

Aug 2025: The FDA granted Fast Track designation to the investigational therapy stenoparib for advanced ovarian cancer, which uses a companion diagnostic (DRP) to identify likely responders, accelerating its development and review.

Aug 2025: Scientists identified sixteen potential therapeutic targets in low-grade serous ovarian cancer by studying proteins at the molecular level, which may guide future diagnostic and treatment development.

List of the Key Players in the Ovarian Cancer Diagnostics Market:

F. Hoffmann-La Roche Ltd.
Siemens Healthcare GmbH
Quest Diagnostics Incorporated
Thermo Fisher Scientific
Abbott
Myriad Genetic Laboratories, Inc.
Foundation Medicine, Inc.
Laboratory Corporation of America Holdings.

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=ovarian-cancer-diagnostics-market

Segments Covered in the Ovarian Cancer Diagnostics Market:

By Diagnosis Type: Imaging, Blood Test, Biopsy, Others.

By Cancer Type: Epithelial Tumor, Stromal Cell Tumor, Germ Cell Tumor, Others.

By End-User: Hospitals, Cancer Diagnostic Centers, Others.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/ovarian-cancer-diagnostics-market?sz

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Ovarian Cancer Diagnostics market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Ovarian Cancer Diagnostics Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The Global Ovarian Cancer Diagnostics market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Ovarian Cancer Diagnostics Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Ovarian Cancer Diagnostics Market in 2025?
◆ What is the projected growth rate of the Ovarian Cancer Diagnostics Market through 2033?
◆ Who are the key players in the Ovarian Cancer Diagnostics Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.